While some cancer cells (such as melonama and renal cancers) have an enhanced genetic and epigenetic modulators causing higher constitutive expression of P-gp, majority of other solid tumors induce expression of P-gp as a tumor resistance response following initiation of chemotherapy (9). This evidence concerns the gene PGP and renal carcinoma.